Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $10B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 8.78B 236M Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 18.73B 660M Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Novartis USD 307.76B 15.54B Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
TG Therapeutics USD 5.31B 572M Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026
Xencor USD 893M 200M Mar/2026